Literature DB >> 18042178

Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction.

Imane Nafia1, Diane B Re, Frédérique Masmejean, Christophe Melon, Philippe Kachidian, Lydia Kerkerian-Le Goff, André Nieoullon, Laurence Had-Aissouni.   

Abstract

Nigral depletion of the main brain antioxidant GSH is the earliest biochemical event involved in Parkinson's disease pathogenesis. Its causes are completely unknown but increasing number of evidence suggests that glutamate transporters [excitatory amino acid transporters (EAATs)] are the main route by which GSH precursors may enter the cell. In this study, we report that dopamine (DA) neurons, which express the excitatory amino acid carrier 1, are preferentially affected by EAAT dysfunction when compared with non-DA neurons. In rat embryonic mesencephalic cultures, l-trans-pyrrolidine-2,4-dicarboxylate, a substrate inhibitor of EAATs, is directly and preferentially toxic for DA neurons by decreasing the availability of GSH precursors and lowering their resistance threshold to glutamate excitotoxicity through NMDA-receptors. In adult rat, acute intranigral injection of l-trans-pyrrolidine-2,4-dicarboxylate induces a large regionally selective and dose-dependent loss of DA neurons and alpha-synuclein aggregate formation. These data highlight for the first time the importance of excitatory amino acid carrier 1 function for the maintenance of antioxidant defense in DA neurons and suggest its dysfunction as a candidate mechanism for the selective death of DA neurons such as occurring in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042178     DOI: 10.1111/j.1471-4159.2007.05146.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.

Authors:  Ari E Berman; Wai Yee Chan; Angela M Brennan; Reno C Reyes; Brittany L Adler; Sang Won Suh; Tiina M Kauppinen; Ylva Edling; Raymond A Swanson
Journal:  Ann Neurol       Date:  2010-11-23       Impact factor: 10.422

Review 2.  Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.

Authors:  Timothy J Collier; Nicholas M Kanaan; Jeffrey H Kordower
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

3.  Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression.

Authors:  Carole Escartin; Seok Joon Won; Carole Malgorn; Gwennaelle Auregan; Ari E Berman; Pei-Chun Chen; Nicole Déglon; Jeffrey A Johnson; Sang Won Suh; Raymond A Swanson
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

4.  MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.

Authors:  S Gouty; J M Brown; J Rosenberger; B M Cox
Journal:  Neuroscience       Date:  2010-04-22       Impact factor: 3.590

5.  Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.

Authors:  Xing-Long Gu; Cai-Xia Long; Lixin Sun; Chengsong Xie; Xian Lin; Huaibin Cai
Journal:  Mol Brain       Date:  2010-04-21       Impact factor: 4.041

6.  Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.

Authors:  Diana L Price; Edward Rockenstein; Kiren Ubhi; Van Phung; Natalie MacLean-Lewis; David Askay; Anna Cartier; Brian Spencer; Christina Patrick; Paula Desplats; Mark H Ellisman; Eliezer Masliah
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

7.  Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Authors:  Tanya Chotibut; Richard W Davis; Jennifer C Arnold; Zachary Frenchek; Shawn Gurwara; Vimala Bondada; James W Geddes; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-12-03       Impact factor: 5.590

8.  Effects of Glycyrrhetinic Acid on GSH Synthesis Induced by Realgar in the Mouse Hippocampus: Involvement of System [Formula: see text], System [Formula: see text], MRP-1, and Nrf2.

Authors:  Yan-Lei Wang; Mo Chen; Tao-Guang Huo; Ying-Hua Zhang; Ying Fang; Cong Feng; Shou-Yun Wang; Hong Jiang
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

Review 9.  Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.

Authors:  Massimiliano G Bianchi; Donatella Bardelli; Martina Chiu; Ovidio Bussolati
Journal:  Cell Mol Life Sci       Date:  2013-10-26       Impact factor: 9.261

Review 10.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.